Prostate Cancer International is
for 2011 by Great NonProfits
According to new data presented at the Frontiers in Cancer Prevention Research meeting ongoing this week in Boston, MA, some 70 percent of prostate cancer patients participating in a survey in Michigan reported long-term, treatment-related, adverse effects after first-line treatment with surgery or radiation therapy.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, follow-up, lontg-term, radiation, surgery | 6 Comments »
An article by Schmitges et al., originally published in Therapeutic Advances in Urology in August this year, has just been reproduced on the Medscape Oncology web site, where it is available in complete form.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: "high risk", surgery | 8 Comments »
A report just published on line in Nature Medicine describes the first use of intraoperative, tumor-specific fluorescence imaging to highlight the precise position of small groups of cancer cells in women with ovarian cancer, thereby allowing the surgeon to carefully excise such small groups of cells.
Filed under: Management, Treatment | Tagged: cells, excision, fluorescence, imaging, surgery, tumor | Leave a Comment »
Academic research into the side effects of different treatments for localized prostate cancer have long been hampered by the lack of consistently used criteria for the assessment of those side effects at baseline and at defined time-periods post-treatment.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: EBRT, laparoscopic, radiation therapy, radical prostatectomy, RALP, robot-assisted, side effects, surgery | 3 Comments »
It is sometimes amazing how little some physicians appear to understand about the side effects of the treatments that they give to their patients! If these were really rare side effects it might be understandable, but the one we shall discuss below is far from rare …
Filed under: Management, Treatment | Tagged: climacturia, incontinence, radical prostatectomy, sexual activity, surgery | 9 Comments »
In a new paper just published on-line in the Journal of Urology, Kapoor et al. have provided data on trends in the utilization of various major types of treatment for the management of localized prostate cancer among Medicare beneficiaries in the USA between 2006 and 2008.
Filed under: Management, Treatment | Tagged: beneficiary, cryotherapy, Medicare, radiation, surgery, Treatment, utilization | Leave a Comment »
A very small (pilot scale), randomized, clinical trial has provided some evidence that combining the use of a vacuum erection device (VED) with taldalafil (Cialis) drug therapy after bilateral, nerve-sparing robot-assisted laparoscopic prostatectomy (BNS-RALP) can improve the probability of return of erectile function post-surgery.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bilateral, nerve-sparing, surgery, taldalafil, vacuum erection device, VED | Leave a Comment »
Two articles and an associated editorial, currently in press in the Journal of Urology, offer insight into the pre-treatment expectations and the post-treatment realities of men who decide to have surgical treatment for localized prostate cancer.
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: decision-making, expectation, outcome, surgery | 4 Comments »
The University of California, San Francisco (UCSF) Cancer of the Prostate Risk Assessment (CAPRA) score was initially introduced in 2005 and validated in 2006 as a pre-treatment tool that could be used to assess risk for prostate cancer recurrence after first-line treatment.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: CAPRA, CAPRA-S, prognosis, recurrence, risk, surgery | 7 Comments »
Let us be clear up front … Duloxetine (Cymbalta®) has not been approved anywhere in the world that we are aware of as a treatment for post-surgical incontinence in men treated for prostate cancer, and there has never been a large, randomized, double-blind Phase III trial to try to demonstrate such activity.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: duloxetine, incontinence, stress, surgery | Leave a Comment »
We are coming to the conclusion that there is a deep divide between how some surgeons think about post-surgical incontinence following radical prostatectomy for their prostate cancer and how patients may think about such incontinence when defined by exactly the same set of clinical symptoms and quality of life issues.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: continence, incontinence, laparoscopic, prostatectomy, RALP, robot-assisted, surgery | Leave a Comment »
So Dr. Timothy Wilt presented the initial results of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) at the annual meeting of the AUA yesterday morning. They showed what many of us may have been expecting.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: benefit, observation, outcome, PIVOT, surgery | 22 Comments »
Back in June 2010, we reported on the initial results of SWOG 9921 — a trial that randomized 983 men with high-risk features at prostatectomy to receive adjuvant therapy with androgen deprivation (ADT) alone or in combination with mitoxantrone chemotherapy.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", adjuvant, ADT, androgen deprivation therapy, surgery | 6 Comments »
Exactly how some of the major, tertiary, specialized prostate cancer centers think about the management of prostate cancer over time needs to be taken into account in evaluation of the data being published by those centers.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: active surveillance, risk, shift, stage, surgery | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site